Concepedia

Yan Dong

YD

Statistics

Publications

11

Citations

562

H-Index

11

Active since

1996

Affiliations

OPKO Health (United States)(Current)

Memorial Sloan Kettering Cancer Center

MBio Diagnostics (United States)

University of California, Santa Cruz

Tufts University

Yan Dong is an author at OPKO Health (United States) specializing in prostate cancer, oncology, and medicine.

ORCID

Publications per year

1996–2018

11

Publications

11

CUS2, a Yeast Homolog of Human Tat-SF1, Rescues Function of Misfolded U2 through an Unusual RNA Recognition Motif

Yan Dong, Rhonda Perriman, Haller Igel et al. · Molecular and Cellular Biology · 1998 · 94 citations · Full text

, , +17

Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study

Daniel W. Lin, Lisa F. Newcomb, Marshall Brown et al. · European Urology · 2016 · 86 citations · Full text

, , +14

Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy

Joshua S. Jue, Marcelo Barboza, Nachiketh Soodana‐Prakash et al. · Urology · 2017 · 81 citations · Full text

, , +16

Invariant U2 RNA Sequences Bordering the Branchpoint Recognition Region Are Essential for Interaction with Yeast SF3a and SF3b Subunits

Yan Dong, Manuel Ares · Molecular and Cellular Biology · 1996 · 63 citations · Full text

, , +16

Clinical performance of the 4Kscore Test to predict high-grade prostate cancer at biopsy: A meta-analysis of us and European clinical validation study results.

Stephen Zappala, Peter T. Scardino, David Okrongly et al. · PubMed · 2017 · 57 citations · Full text

, , +16

1–5 of 11